Jennifer L. Taubert - EVP, WWC. Innovative Medicine at Johnson & Johnson

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, WWC. Innovative Medicine
Stock Symbol
JNJ on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jennifer L. Taubert - trading volume in the past year for Johnson & Johnson

Holdings reported by Jennifer L. Taubert for Johnson & Johnson

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 155 K $24.4 M $157.85 Feb 13, 2024 Direct
Employee Stock Options (Right to Buy) 77 K $6.96 M $90.44 Feb 15, 2024 Direct Common Stock
Restricted Share Units 4.78 K $755 K $157.85 Feb 15, 2024 Direct Common Stock
Performance Share Units 0 $0 $157.40 Feb 12, 2024 Direct Common Stock

Transactions reported by Jennifer L. Taubert for Johnson & Johnson

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership